To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

×
Open menu Search

ATK ammunition plant reaches delivery milestone

17th September 2012 - 10:41 GMT | by The Shephard News Team

RSS

ATK’s Lake City Army Ammunition Plant (LCAAP) has reached a significant delivery milestone by delivering the 2 billionth 7.62mm round of ammunition manufactured at the plant since its assumption of manufacturing operations in 2000. In that time the company has increased the production rate for 7.62mm ammunition five-fold in direct support of US Army requirements.

In partnership with the US Army, ATK has successfully implemented a complex expansion and modernisation programme at LCAAP that has resulted in increasing plant production from 374 million to more than 1.6 billion rounds annually. This includes high-volume deliveries of the US Army's M855A1 Enhanced Performance Round (EPR) on modernised equipment. The EPR is an enhanced version of the M855 5.56mm cartridge and offers a significant breakthrough in ammunition performance. ATK has delivered more than 350 million M855A1 rounds since transitioning to production in 2010.

According to the company, it has implemented a ‘unique lean manufacturing system’ that focuses on maximising efficiencies and eliminating waste. It has also initiated a system that employs cellular manufacturing processes, integrated enterprise information systems, and advanced material handling capabilities designed to enhance production efficiencies and throughput.

ATK received recent orders totaling $131 million for small-caliber ammunition under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the US Army Contracting Command, Rock Island (ACC-RI). These orders include a mix of 5.56mm, 7.62mm and .50-caliber military ammunition to be produced at LCAAP.

The Shephard News Team

Author

The Shephard News Team


As part of our promise to deliver comprehensive coverage to Premium News and Defence Insight …

Read full bio

Share to

Linkedin